BioCentury's websites will be down for upgrades starting at 11 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:02 PM
Feb 06, 2009
 |  BC Extra  |  Company News

GSK in-licenses Idenix's IDX899

Idenix (NASDAQ:IDIX) granted GlaxoSmithKline (LSE:GSK; NYSE:GSK) an exclusive, worldwide license to IDX899. The once-daily non-nucleoside...

Read the full 70 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >